Terminated NCT00977522
This study was terminated in the United States. It is testing PF-03463275 for schizophrenia.
Multiple locations, including Cerritos Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug i A study involving a medication or substance. From 18 Years to 55 Years
Countries United States
Sponsor Pfizer
Condition Schizophrenia Terminated NCT00256997
This study was terminated in Australia, in Canada, in the United Kingdom, .... It is testing Risperidone Long-Acting Injection Versus Oral Antipsychotics for schizophrenia.
Multiple locations, including Dandenong Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries Australia, Canada, United Kingdom, ...
Sponsor Janssen-Ortho Inc., Canada
Condition Schizophrenia Completed NCT01234779
This study is completed in the United States, in Romania, in Russia, .... It is testing RO4917838 (Bitopertin) for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 65 Years
Countries United States, Romania, Russia, ...
Sponsor Hoffmann-La Roche
Condition Schizophrenia Completed NCT01192906
This study is completed in the United States, in Canada, in Brazil, .... It is testing RO4917838 (Bitopertin) for schizophrenia.
Multiple locations, including Carson Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States, Canada, Brazil, ...
Sponsor Hoffmann-La Roche
Condition Schizophrenia Completed NCT01235559
This study is completed in the United States, in Bulgaria, in China, .... It is testing RO4917838 (Bitopertin) for schizophrenia.
Multiple locations, including Costa Mesa Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States, Bulgaria, China, ...
Sponsor Hoffmann-La Roche
Condition Schizophrenia Completed NCT01235585
This study is completed in the United States, in Canada, in Brazil, .... It is testing RO4917838 (Bitopertin) for schizophrenia.
Multiple locations, including Carson Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States, Canada, Brazil, ...
Sponsor Hoffmann-La Roche
Condition Schizophrenia Completed NCT00616798
This study is completed in the United States, in France, in Austria, .... It is testing RO4917838 for schizophrenia.
Multiple locations, including Granada Hills Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 60 Years
Countries United States, France, Austria, ...
Sponsor Hoffmann-La Roche
Condition Schizophrenia Completed NCT01192867
This study is completed in the United States, in Australia, in France, .... It is testing RO4917838 for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States, Australia, France, ...
Sponsor Hoffmann-La Roche
Condition Schizophrenia Completed NCT01235520
This study is completed in the United States, in Australia, in France, .... It is testing RO4917838 for schizophrenia.
Multiple locations, including Little Rock Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug Over 18 Years
Countries United States, Australia, France, ...
Sponsor Hoffmann-La Roche
Condition Schizophrenia Completed NCT03273439
This study is completed. It is testing rTMS for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Device i A study involving a tool, app, wearable, test, or medical device. From 18 Years to 60 Years
Countries
Sponsor Suzhou Psychiatric Hospital
Condition Schizophrenia Completed NCT00077727
This study is completed. It is testing effectiveness and Safety of Galantamine Hydrobromide on Cognitive Impairment for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries
Sponsor Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Condition Schizophrenia Completed NCT00253136
This study is completed. It is testing Effectiveness and Safety of Long-acting Injectable Risperidone for schizophrenia.
Location not clearly listed Why is this study shown? This study is directly about Schizophrenia.
Schizophrenia Drug From 18 Years to 55 Years
Countries
Sponsor Janssen, LP
Condition Schizophrenia